PRESS RELEASE published on 11/06/2023 at 14:30, 1 year ago BioStem Technologies to Report Third Quarter 2023 Financial Results on Tuesday, November 14, 2023
PRESS RELEASE published on 10/24/2023 at 14:30, 1 year ago BioStem Technologies Announces Opening of First Clinical Site for Diabetic Foot Ulcer Study
PRESS RELEASE published on 10/18/2023 at 14:30, 1 year 1 month ago BioStem Technologies to Present at the Fall Foliage MicroCap Rodeo Conference
PRESS RELEASE published on 10/17/2023 at 18:10, 1 year 1 month ago BioStem Technologies to Highlight Core Advanced Wound Care Portfolio at SAWC Fall 2023 Conference
PRESS RELEASE published on 09/29/2023 at 14:30, 1 year 1 month ago BioStem Technologies: CMS Decision a “Win For Patients”
PRESS RELEASE published on 09/26/2023 at 14:30, 1 year 1 month ago BioStem Receives IRB Approval for Clinical Study to Evaluate Vendaje(R) in Diabetic Foot Ulcers
PRESS RELEASE published on 09/19/2023 at 14:00, 1 year 2 months ago BioStem Technologies Initiates Nationwide Launch of AmnioWrap2(TM) with Venture Medical
PRESS RELEASE published on 09/18/2023 at 14:30, 1 year 2 months ago BioStem Technologies Engages PCG Advisory for Strategic Investor Relations
Published on 11/21/2024 at 10:03, 54 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 57 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 57 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 22 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 32 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:30, 27 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 52 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 55 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 57 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 57 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 06:58, 3 hours 59 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 37 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 12 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 12 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
